Ganesh Benzoplast Ltd

Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.

Ganesh Benzoplast Ltd trades at ₹105, in a confirmed uptrend and 8 weeks into that stage. That is +10.7% against its own 200-day average. It sits at 83% of a 52-week range of ₹70 to ₹112. On relative strength it has been ahead of the NIFTY 500 on a trailing-13-week view for 1 straight week.

Today the stock is in a confirmed uptrend — week 8 of stage 2, confirmed. At ₹105 it trades +10.7% versus its 200-day average and sits at 83% of its 52-week range (₹70–₹112).

Against the market, two honest reads. Cumulative: over the last 10.3 years the stock moved +408% while the NIFTY 500 moved +266% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 1 straight week — the ribbon below is that same metric, week by week.

What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.

→ The trend is one thing; the bill is another. Are you paying up for it? Next: the P/E sits at the 48th percentile of its own range.

Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.

Ganesh Benzoplast Ltd trades at 12.0× P/E, mid-range by its own standards (48th percentile). Its long-run median P/E is 13.7×, measured across 7.1 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.

Today's P/E of 12.0× is mid-range by its own standards (48th percentile), against a long-run median of 13.7× measured over 7.1 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.

Why the multiple sits where it does: over the past year annual EPS moved +92.6% against a +7.7% price move — earnings outran the price, pushing the multiple DOWN its own range.

The price move, decomposed: over 5y, of the +4.0%/yr price move, ~+13.9%/yr came from earnings growth and ~−9.9 pp from the multiple (compressing). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.

Put together: the multiple is unremarkable against its own past, so the story rests on the earnings line underneath it, not the multiple.

A quarterly PEG curve, which only the second data source carries, is not drawn on this page: its two data sources do not share enough overlapping reported history to be compared. A figure nobody could check is not used to price growth — the gap is a decision, not missing data.

→ Cheap or dear rides on the earnings. Are they actually growing? Next: the fundamental stage — where the business sits in its arc, and how growth has compounded.

Stage: Turning around Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).

Ganesh Benzoplast Ltd reads as turning around on its fundamental arc. Turning around — profit growth swung from −37.1% at the trough to +97.3%, a 3-quarter improving streak, ROCE slipping at 15.0%. The read is built from 8 quarters across 4 curves, on partial evidence.

Why it matters: growth inflections are where re-ratings start — the curves say a turn is forming, so the question becomes whether the next quarters confirm it.

Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.

A partial read: at least one curve is short, or the returns curve is not the computed quarterly series — hold the stage word a little more loosely.

→ The stage names the trajectory. Next: the revenue line that produces it, quarter by quarter.

4-Factor Sector Score

50.8/100 — rank 3 of 9 in Chemicals - Inorganic · 62% evidence confidence

Ganesh Benzoplast Ltd scores 50.8 out of 100 against the 9 companies it is compared with in Chemicals - Inorganic, ranking 3. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.

The four contributions add to the total exactly: 11.7 + 15.6 + 11.1 + 12.4 = 50.8. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.

What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.

Revenue Revenue is the top line: everything the company billed its customers in the period.

Ganesh Benzoplast Ltd reported ₹111 Cr of revenue in the Mar 26 quarter, +11.0% year on year. That is the 4th straight quarter of year-on-year growth. Over 10 years it has compounded at 13.2% a year. The last full year, FY26, came in at ₹411 Cr. The last four reported quarters add to ₹411 Cr.

Ganesh Benzoplast Ltd reported ₹111 Cr of revenue in the Mar 26 quarter, +11.0% year on year. That is the 4th straight quarter of year-on-year growth. Over 10 years it has compounded at 13.2% a year. The last full year, FY26, came in at ₹411 Cr. The last four reported quarters add to ₹411 Cr.

FY26 revenue came in at ₹411 Cr (+9.9% on the year), capping 10 years at 13.2% compound. The latest quarter (Mar 26) printed ₹111 Cr, +11.0% year on year — the 4th consecutive quarter of year-over-year growth.

Pace check: the last four quarters averaged +9.8% growth against the decade's 13.2% — the current year is running slower than its own long-run rate.

Acceleration check: trailing-twelve-month revenue grew +9.6% over the last 4 quarters against −7.2%/yr over the last 8 — accelerating; TTM profit +97.3% vs +9.4%/yr — accelerating.

→ Revenue grew — did margins hold as it scaled? Next: 18.0% this quarter (−14.0 pp YoY).

Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.

Ganesh Benzoplast Ltd's operating margin is 18.0% in the Mar 26 quarter, −14.0 percentage points against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged 17.0% to 32.0%. The current quarter sits inside that band.

Ganesh Benzoplast Ltd's operating margin is 18.0% in the Mar 26 quarter, −14.0 percentage points against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged 17.0% to 32.0%. The current quarter sits inside that band.

The latest quarter's operating margin is 18.0%, −14.0 pp against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged 17.0%–32.0%.

🚨 Why the margin moved: operating margin went −13.2 pp year on year while gross margin went −7.2 pp — the loss came mostly below the gross line: operating leverage, with costs spread over a bigger revenue base.

→ Margins slipped — did that reach the bottom line? Next: profit null in the latest quarter.

Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.

Ganesh Benzoplast Ltd earned ₹15.0 Cr of net profit in the Mar 26 quarter. Full-year FY26 profit was ₹73.0 Cr. The 10-year compound rate is 4.3%. That is 13.5% of the quarter's revenue. The same quarter a year earlier lost ₹13.0 Cr. 1 of the last 12 reported quarters were loss-making.

Ganesh Benzoplast Ltd earned ₹15.0 Cr of net profit in the Mar 26 quarter. Full-year FY26 profit was ₹73.0 Cr. The 10-year compound rate is 4.3%. That is 13.5% of the quarter's revenue. The same quarter a year earlier lost ₹13.0 Cr. 1 of the last 12 reported quarters were loss-making.

Mar 26 profit was ₹15.0 Cr, null year on year. On the full year, FY26 printed ₹73.0 Cr (+92.1%), and the 10-year compound rate is 4.3%.

Pace comparison, last four quarters: profit +17.1% vs revenue +9.8%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra rupee of revenue drops more to the bottom line.

→ Profit rose — but did the cash follow? Next: 126% of the last 3 years' profit arrived as cash.

Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.

Over the last 3 fiscal years 126% of Ganesh Benzoplast Ltd's reported profit arrived as operating cash — the cash follows the profit. In FY26 that was ₹79.0 Cr of operating cash against ₹73.0 Cr of profit. After ₹69.0 Cr of capital spending, ₹10.0 Cr was left as free cash.

FY26: operating cash of ₹79.0 Cr against reported profit of ₹73.0 Cr, leaving free cash of ₹10.0 Cr after ₹69.0 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 126% of profit.

Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.

Why conversion sits at 126%: the cash cycle stretched 158 days between FY21 and FY26 — more of each rupee of profit waits inside the cycle before arriving.

Router verdict: the bigger cash user is investment — capital spending ran 2.8× depreciation over three years, so the next section's job is to check what that build-out is buying.

→ So follow the cash to where it goes. Next: ₹187 Cr of building over 3 years.

Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).

Ganesh Benzoplast Ltd's cash conversion cycle runs 36 days in FY26, up from −122 days in FY21. Capital spending ran ₹187 Cr over the last 3 years. At FY26 sales of ₹411 Cr each day of that cycle holds about ₹1.1 Cr, so roughly ₹41.0 Cr sits inside the business at any moment.

FY26: debtors at 49 days, inventory at 129 days — roughly 4.2 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 36 days, looser than FY21's −122.

The full loop: cash goes out to suppliers and production on day 0; stock waits 129 days to sell; customers pay about 49 days after that; and suppliers themselves are paid at 142 days — netting out to the 36-day cycle.

In money terms: at FY26 sales of ₹411 Cr, each day of the cycle holds about ₹1.1 Cr — so the 36-day loop keeps roughly ₹41.0 Cr sitting inside the business at any moment.

On the investment side: capital spending of ₹187 Cr over the last 3 fiscal years against ₹66.0 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹21.0 Cr (FY26) — capacity paid for but not yet earning.

The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.

→ Does all this activity actually earn its cost of capital? Next: ROCE is 15% and the ROIC − WACC spread is −2.9 pp.

Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.⚠ unverified

Ganesh Benzoplast Ltd earns a ROCE of 15% in FY26. That is up from a trough of 2% in FY15. Return on invested capital clears the cost of that capital by −2.9 percentage points, so growth here is not yet paying for the capital it uses. The wiring behind it is 17.8% net margin on 0.48× asset turns.

FY26 ROCE is 15%, recovered from a FY15 trough of 2% — the full ladder below shows the fall and the climb, undoctored.

🚨 Why the return is what it is — the wiring (FY26): 17.8% net margin × 0.48× asset turns × 1.39× balance-sheet leverage ≈ 11.9% on equity. Margin is doing the heavy lifting; leverage is modest — this is an earned return, not a borrowed one.

The capstone test — ROIC − WACC: 9.1% − 12.0% = a −2.9 pp spread. The 12.0% is a standing assumption for the cost of capital in India, not a per-stock estimate — read the sign and the size of the spread, not the decimals. Negative — growth at these returns destroys value until the returns recover.

→ Returns like these — is the balance sheet borrowing to make them? Next: debt-to-equity is 0.12.

Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.⚠ unverified

Ganesh Benzoplast Ltd carries total debt of ₹76.0 Cr against shareholder equity of ₹618 Cr as of Mar 26, a debt-to-equity of 0.12 — effectively unlevered. On the annual view that ratio went from 0.09 in FY22 to 0.12 in FY26. The returns elsewhere on this page are therefore earned rather than borrowed.

Mar 26: total debt of ₹76.0 Cr against shareholder equity of ₹618 Cr — a debt-to-equity of 0.12. On the annual view, debt-to-equity went from 0.09 (FY22) to 0.12 (FY26). The returns on this page are earned, not borrowed.

→ Who owns this, and are they adding or leaving? Next: Foreign institutions cut 4.1 points over 8 quarters.

Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.

Foreign institutions cut 4.1 points of Ganesh Benzoplast Ltd over 8 quarters, the biggest move on the register. That takes foreign institutions to 1.1% of the company. Domestic institutions moved +1.0 points over the same window, to 1.0%. The register is read on the four disclosed classes only; nothing is inferred between filings.

The register over the last two years — Foreign institutions: −4.1 points over 8 quarters to 1.1%; Domestic institutions: +1.0 points over 8 quarters to 1.0%; Promoters: +0.0 points over 8 quarters to 39.0%.

🚨 Why the register moved: foreign institutions drove it (−4.1 points), absorbed on the other side by domestic institutions (+1.0 points) — distribution into the market’s bid.

→ One last check: does the safety math agree? Next: the balance-sheet safety line.

Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.

Ganesh Benzoplast Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.

The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.

Frequently asked questions